vs
CALIX, INC（CALX）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
CALIX, INC的季度营收约是REPLIGEN CORP的1.4倍（$280.0M vs $194.3M），REPLIGEN CORP净利率更高（4.3% vs 4.0%，领先0.3%），CALIX, INC同比增速更快（27.1% vs 14.8%），过去两年CALIX, INC的营收复合增速更高（18.9% vs 12.3%）
Calix是1999年成立、总部位于美国加利福尼亚州圣何塞的电信企业，专注于提供软件平台、系统及相关服务，为宽带业务的部署落地提供技术支撑，助力运营商为用户提供稳定高效的网络接入服务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
CALX vs RGEN — 直观对比
营收规模更大
CALX
是对方的1.4倍
$194.3M
营收增速更快
CALX
高出12.3%
14.8%
净利率更高
RGEN
高出0.3%
4.0%
两年增速更快
CALX
近两年复合增速
12.3%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $280.0M | $194.3M |
| 净利润 | $11.2M | $8.3M |
| 毛利率 | 56.9% | 55.7% |
| 营业利润率 | 47.6% | 8.2% |
| 净利率 | 4.0% | 4.3% |
| 营收同比 | 27.1% | 14.8% |
| 净利润同比 | — | 42.9% |
| 每股收益（稀释后） | $0.16 | $0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CALXRGEN
| Q1 26 | $280.0M | $194.3M | ||
| Q4 25 | $272.4M | $197.9M | ||
| Q3 25 | $265.4M | $188.8M | ||
| Q2 25 | $241.9M | $182.4M | ||
| Q1 25 | $220.2M | $169.2M | ||
| Q4 24 | $206.1M | $174.1M | ||
| Q3 24 | $200.9M | $154.9M | ||
| Q2 24 | $198.1M | $154.1M |
净利润CALXRGEN
| Q1 26 | $11.2M | $8.3M | ||
| Q4 25 | $7.2M | $13.3M | ||
| Q3 25 | $15.7M | $14.9M | ||
| Q2 25 | $-199.0K | $14.9M | ||
| Q1 25 | $-4.8M | $5.8M | ||
| Q4 24 | $-17.9M | $-30.3M | ||
| Q3 24 | $-4.0M | $-654.0K | ||
| Q2 24 | $-8.0M | $3.3M |
毛利率CALXRGEN
| Q1 26 | 56.9% | 55.7% | ||
| Q4 25 | 57.7% | 52.5% | ||
| Q3 25 | 57.3% | 53.2% | ||
| Q2 25 | 56.3% | 50.0% | ||
| Q1 25 | 55.7% | 53.6% | ||
| Q4 24 | 55.0% | 26.1% | ||
| Q3 24 | 54.8% | 50.0% | ||
| Q2 24 | 54.3% | 49.8% |
营业利润率CALXRGEN
| Q1 26 | 47.6% | 8.2% | ||
| Q4 25 | 3.4% | 9.0% | ||
| Q3 25 | 6.6% | 8.9% | ||
| Q2 25 | 0.2% | 7.6% | ||
| Q1 25 | -2.8% | 3.9% | ||
| Q4 24 | -9.1% | -17.7% | ||
| Q3 24 | -5.4% | -5.1% | ||
| Q2 24 | -5.7% | 1.0% |
净利率CALXRGEN
| Q1 26 | 4.0% | 4.3% | ||
| Q4 25 | 2.6% | 6.7% | ||
| Q3 25 | 5.9% | 7.9% | ||
| Q2 25 | -0.1% | 8.2% | ||
| Q1 25 | -2.2% | 3.4% | ||
| Q4 24 | -8.7% | -17.4% | ||
| Q3 24 | -2.0% | -0.4% | ||
| Q2 24 | -4.0% | 2.2% |
每股收益（稀释后）CALXRGEN
| Q1 26 | $0.16 | $0.15 | ||
| Q4 25 | $0.11 | $0.24 | ||
| Q3 25 | $0.22 | $0.26 | ||
| Q2 25 | $0.00 | $0.26 | ||
| Q1 25 | $-0.07 | $0.10 | ||
| Q4 24 | $-0.27 | $-0.55 | ||
| Q3 24 | $-0.06 | $-0.01 | ||
| Q2 24 | $-0.12 | $0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $54.6M | $582.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $738.0M | — |
| 总资产 | — | $2.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CALXRGEN
| Q1 26 | $54.6M | $582.6M | ||
| Q4 25 | $143.1M | $767.6M | ||
| Q3 25 | $95.0M | $748.7M | ||
| Q2 25 | $76.5M | $708.9M | ||
| Q1 25 | $42.3M | $697.2M | ||
| Q4 24 | $43.2M | $757.4M | ||
| Q3 24 | $62.4M | $784.0M | ||
| Q2 24 | $84.5M | $809.1M |
总债务CALXRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益CALXRGEN
| Q1 26 | $738.0M | — | ||
| Q4 25 | $859.2M | $2.1B | ||
| Q3 25 | $822.5M | $2.1B | ||
| Q2 25 | $772.7M | $2.1B | ||
| Q1 25 | $767.2M | $2.0B | ||
| Q4 24 | $780.9M | $2.0B | ||
| Q3 24 | $778.7M | $2.0B | ||
| Q2 24 | $754.2M | $2.0B |
总资产CALXRGEN
| Q1 26 | — | $2.9B | ||
| Q4 25 | $1.1B | $2.9B | ||
| Q3 25 | $976.4M | $2.9B | ||
| Q2 25 | $921.4M | $2.9B | ||
| Q1 25 | $917.1M | $2.9B | ||
| Q4 24 | $939.3M | $2.8B | ||
| Q3 24 | $937.5M | $2.8B | ||
| Q2 24 | $917.9M | $2.9B |
负债/权益比CALXRGEN
| Q1 26 | — | — | ||
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.6M | — |
| 自由现金流经营现金流 - 资本支出 | $6.5M | — |
| 自由现金流率自由现金流/营收 | 2.3% | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 1.31× | — |
| 过去12个月自由现金流最近4个季度 | $109.1M | — |
8季度趋势，按日历期对齐
经营现金流CALXRGEN
| Q1 26 | $14.6M | — | ||
| Q4 25 | $46.0M | $25.7M | ||
| Q3 25 | $32.3M | $48.1M | ||
| Q2 25 | $39.4M | $28.6M | ||
| Q1 25 | $17.2M | $15.0M | ||
| Q4 24 | $15.4M | $39.2M | ||
| Q3 24 | $16.0M | $49.3M | ||
| Q2 24 | $22.3M | $42.2M |
自由现金流CALXRGEN
| Q1 26 | $6.5M | — | ||
| Q4 25 | $40.3M | $17.6M | ||
| Q3 25 | $26.7M | $43.4M | ||
| Q2 25 | $35.6M | $21.5M | ||
| Q1 25 | $12.9M | $11.4M | ||
| Q4 24 | $10.2M | $33.6M | ||
| Q3 24 | $12.8M | $42.3M | ||
| Q2 24 | $16.4M | $37.4M |
自由现金流率CALXRGEN
| Q1 26 | 2.3% | — | ||
| Q4 25 | 14.8% | 8.9% | ||
| Q3 25 | 10.1% | 23.0% | ||
| Q2 25 | 14.7% | 11.8% | ||
| Q1 25 | 5.9% | 6.8% | ||
| Q4 24 | 5.0% | 19.3% | ||
| Q3 24 | 6.3% | 27.3% | ||
| Q2 24 | 8.3% | 24.3% |
资本支出强度CALXRGEN
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | 4.1% | ||
| Q3 25 | 2.1% | 2.5% | ||
| Q2 25 | 1.5% | 3.9% | ||
| Q1 25 | 2.0% | 2.1% | ||
| Q4 24 | 2.5% | 3.2% | ||
| Q3 24 | 1.6% | 4.5% | ||
| Q2 24 | 3.0% | 3.1% |
现金转化率CALXRGEN
| Q1 26 | 1.31× | — | ||
| Q4 25 | 6.38× | 1.93× | ||
| Q3 25 | 2.06× | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CALX
| Appliance | $232.8M | 83% |
| Software and service | $47.1M | 17% |
RGEN
| Product | $194.2M | 100% |
| Royalty and other revenue | $44.0K | 0% |
